Please assess the completion status of the following clinical trial:

Trial Title: Routine Pregnancy Screening for Women on Opioid Substitution Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* currently on methadone or buprenorphine maintenance therapy~* have some male sexual partners~Exclusion Criteria:~* females who have exclusively female sexual partners~* a previous diagnosis of premature menopause~* hysterectomy, oophorectomy, and/or tubal ligation~* current pregnancy~* current intrauterine device (hormonal or non-hormonal)~* unable to give informed consent in English

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Monthly Pregnancy Screening (Type: EXPERIMENTAL): Patients at the Hamilton Clinic present to the clinic most often on a weekly basis to provide a urine sample for urine drug screening and to meet with their MRP. This same urine sample will be tested for pregnancy in the intervention group once per month. Resulting positive test results will be reported to the patient through their attending physician on the day of testing.
- Usual Care (Type: ACTIVE_COMPARATOR): Participants in the control group will not receive study-initiated urine pregnancy testing but will receive usual care, which may include pregnancy testing based on patient request or clinical judgement.

Based on this trial design, predict the completion outcome and termination type (if applicable).